CRON
$5.01
Cronos Group
CRON
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.06)
Revenue:  $10.83 Mil
Thursday
Nov 5
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, August 6, 2020

What do you expect when CRON reports earnings?
Beat
Meet
Miss

Where is CRON's stock price going from here?
Up
Flat
Down
Stock chart of CRON
Analysts
Summary of analysts' recommendations for CRON
Score
Grade
Pivots
Resistance
$5.27
$5.22
$5.11

$5.06

Support
$4.95
$4.90
$4.79
Tweet
Growth
Description
Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as PharmaCan Capital Corp., is headquartered in Toronto, Canada.